Pediatric Surgery International

, Volume 27, Issue 8, pp 805–809 | Cite as

Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review

  • João Moreira-PintoEmail author
  • Paula Rocha
  • Angélica Osório
  • Berta Bonet
  • Fátima Carvalho
  • Carlos Duarte
  • Luísa Oliveira
Review Article


Chylothorax is a well-recognized complication after neonatal cardiothoracic surgery. Management strategies include cessation of enteral feedings, repeated aspiration, chest drainage, and total parenteral nutrition. Somatostatin and its analogue, octreotide, have been used with promising results. The authors present three cases of neonatal postoperative chylothorax in which octreotide was used. After literature review, we can say that octreotide is relatively safe, and may reduce clinical course and complications associated with neonatal postoperative chylothorax. One should be aware of possible association between octreotide and necrotizing enterocolitis. Prospective controlled trials supporting octreotide use are lacking.


Chylothorax Newborn Congenital heart disease Congenital diaphragmatic hernia Esophageal atresia Octreotide 


  1. 1.
    Gonzalez R, Bryner BS, Teitelbaum DH, Hirschl RB, Drongowski RA, Mychaliska GB (2009) Chylothorax after congenital diaphragmatic hernia repair. J Pediatr Surg 44:1181–1185PubMedCrossRefGoogle Scholar
  2. 2.
    Goyal A, Smith NP, Jesudason EC, Kerr S, Losty PD (2003) Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. J Pediatr Surg 38:E19–E20PubMedCrossRefGoogle Scholar
  3. 3.
    Au M, Weber TR, Fleming RE (2003) Successful use of somatostatin in a case of neonatal chylothorax. J Pediatr Surg 38:1106–1107PubMedCrossRefGoogle Scholar
  4. 4.
    Matsukuma E, Aoki Y, Sakai M, Kawamoto N, Watanabe H, Iwagaki S, Takahashi Y et al (2009) Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide. J Pediatr Surg 44:e37–e39PubMedCrossRefGoogle Scholar
  5. 5.
    Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL (2003) Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone–iodine (betadine). Arch Dis Child Fetal Neonatal Ed 88:F531–F533PubMedCrossRefGoogle Scholar
  6. 6.
    Ulíbarri JI, Sanz Y, Fuentes C, Mancha A, Aramendia M, Sánchez S (1990) Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 336:258PubMedCrossRefGoogle Scholar
  7. 7.
    Buettiker V, Hug MI, Burger R, Baenziger O (2001) Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 27:1083–1086PubMedCrossRefGoogle Scholar
  8. 8.
    Glaser B, Hirsch HJ, Landau H (1993) Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 123:644–650PubMedCrossRefGoogle Scholar
  9. 9.
    Siu SL, Lam DS (2006) Spontaneous neonatal chylothorax treated with octreotide. J Paediatr Child Health 42:65–67PubMedCrossRefGoogle Scholar
  10. 10.
    Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med 5:356–357PubMedCrossRefGoogle Scholar
  11. 11.
    Reck-Burneo CA, Parekh A, Velcek FT (2008) Is octreotide a risk factor in necrotizing enterocolitis? J Pediatr Surg 43:1209–1210PubMedCrossRefGoogle Scholar
  12. 12.
    Hung WP, Wang JN, Chang (2009) Octreotide therapy in two children with intractable postoperative chylothorax. Int J Cardiol. doi: 10.1016/j.ijcard.2008.12.210
  13. 13.
    Prada Arias M, Rodriguez Barca P, Carbajosa Herrero MT, de Celis Villasana L, Viñals González F (2008) Chylothorax following repair of oesophageal atresia: conservative treatment with octreotide. An Pediatr (Barc) 69:181–196 (in Spanish)CrossRefGoogle Scholar
  14. 14.
    Copons Fernández C, Benítez Segura I, Castillo Salinas F, Salcedo Abizanda S (2008) Neonatal chylothorax: aetiology, clinical course and efficacy of treatment. An Pediatr (Barc) 68:224–231 (in Spanish)CrossRefGoogle Scholar
  15. 15.
    Rocha G, Henriques-Coelho T, Correia-Pinto J, Guedes MB, Guimarães H (2007) Octreotide for conservative management of postoperative chylothorax in the neonate. Acta Med Port 20:467–470 (in Portuguese)PubMedGoogle Scholar
  16. 16.
    Chan EH, Russel JL, Williams WG (2005) Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg 80:1864–1871PubMedCrossRefGoogle Scholar
  17. 17.
    González Santacruz M, Tarazona Fargueta JL, Muñoz Alvarez P, Mira Navarro J, Jiménez Cobo B (2005) Use of somatostatin in five neonates with chylothorax. An Pediatr (Barc) 63:244–248 (in Spanish)CrossRefGoogle Scholar
  18. 18.
    Tibballs J, Soto R, Bharucha T (2004) Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion. Ann Thorac Surg 77:2213–2215PubMedCrossRefGoogle Scholar
  19. 19.
    Clarke SA, Lakhoo K, Sherwood W (2005) Somatostatin for intractable postoperative chylothorax in a premature infant. Pediatr Surg Int 21:390–391PubMedCrossRefGoogle Scholar
  20. 20.
    Pettitt TW, Caspi J, Borne A (2002) Treatment of persistent chylothorax after Norwood procedure with somatostatin. Ann Thorac Surg 73:977–979PubMedCrossRefGoogle Scholar
  21. 21.
    Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161:149–150PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • João Moreira-Pinto
    • 1
    • 3
    Email author
  • Paula Rocha
    • 2
  • Angélica Osório
    • 1
  • Berta Bonet
    • 1
  • Fátima Carvalho
    • 1
  • Carlos Duarte
    • 2
  • Luísa Oliveira
    • 1
  1. 1.Serviço de Cirurgia PediátricaCentro Hospitalar do PortoPortoPortugal
  2. 2.Pediatric and Neonatal Intensive Care UnitCentro Hospitalar do PortoPortoPortugal
  3. 3.Life and Health Sciences Research InstituteUniversity of MinhoBragaPortugal

Personalised recommendations